{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:25:33Z","timestamp":1789874733192,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFD 0502200"],"award-info":[{"award-number":["2017YFD 0502200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bone.2021.116264","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T02:22:40Z","timestamp":1637634160000},"page":"116264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["CF101 alleviates OA progression and inhibits the inflammatory process via the AMP\/ATP\/AMPK\/mTOR axis"],"prefix":"10.1016","volume":"155","author":[{"given":"Lin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XinYu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianwen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bone.2021.116264_bb0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.berh.2008.02.001","article-title":"Cartilage in normal and osteoarthritis conditions","volume":"22","author":"Martel-Pelletier","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"7","key":"10.1016\/j.bone.2021.116264_bb0010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrrheum.2014.44","article-title":"The individual and socioeconomic impact of osteoarthritis","volume":"10","author":"Hunter","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bone.2021.116264_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11926-008-0006-9","article-title":"Extracellular matrix and pathogenic mechanisms in osteoarthritis","volume":"10","author":"Hardingham","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.bone.2021.116264_bb0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11926-999-0027-z","article-title":"Clinical assessment and significance of inflammation in knee osteoarthritis","volume":"1","author":"Baddour","year":"1999","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.bone.2021.116264_bb0025","first-page":"237","article-title":"The role of cytokines in osteoarthritis pathophysiology","volume":"39","author":"Fernandes","year":"2002","journal-title":"Biorheology"},{"issue":"6","key":"10.1016\/j.bone.2021.116264_bb0030","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"1\u2013278","key":"10.1016\/j.bone.2021.116264_bb0040","first-page":"iii","article-title":"Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation","volume":"12","author":"Chen","year":"2008","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.bone.2021.116264_bb0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2217\/17460816.3.3.253","article-title":"Is there a final common pathway for arthritis?","volume":"3","author":"Malemud","year":"2008","journal-title":"Future Rheumatol."},{"key":"10.1016\/j.bone.2021.116264_bb0050","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F","article-title":"Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets [review]","volume":"44","author":"Pelletier","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bone.2021.116264_bb0060","first-page":"554","article-title":"Osteoarthritis and rheumatoid arthritis pannus have similar qualitative metabolic characteristics and pro-inflammatory cytokine response","volume":"26","author":"Furuzawa-Carballeda","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bone.2021.116264_bb0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11302-015-9460-9","article-title":"Selectivity is species-dependent: characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors","volume":"11","author":"Alnouri","year":"2015","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bone.2021.116264_bb0070","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joca.2006.04.008","article-title":"NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis.","volume":"14","author":"Roman-Blas","year":"2006","journal-title":"Osteoarthritis Cartilage."},{"issue":"9","key":"10.1016\/j.bone.2021.116264_bb0075","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s10067-016-3202-4","article-title":"The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis","volume":"35","author":"Fishman","year":"2016","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.bone.2021.116264_bb0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10059-013-0140-8","article-title":"Autophagy: a critical regulator of cellular metabolism and homeostasis","volume":"36","author":"Ryter","year":"2013","journal-title":"Mol. Cells"},{"key":"10.1016\/j.bone.2021.116264_bb0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/cr.2013.161","article-title":"Autophagy and human diseases","volume":"24","author":"Jiang","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.bone.2021.116264_bb0095","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1056\/NEJMra1205406","article-title":"Autophagy in human health and disease","volume":"368","author":"Choi","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2021.116264_bb0100","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.27305","article-title":"Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis","volume":"62","author":"Carames","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2021.116264_bb0105","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/art.34323","article-title":"Autophagy modulates osteoarthritis-related gene expression in human chondrocytes","volume":"64","author":"Sasaki","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2021.116264_bb0110","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5483\/BMBRep.2015.48.9.259","article-title":"Butein, a tetrahydroxychalcone, suppresses pro-inflammatory responses in HaCaT keratinocytes","volume":"48","author":"Seo","year":"2015","journal-title":"BMB Rep."},{"issue":"1","key":"10.1016\/j.bone.2021.116264_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","article-title":"Osteoarthritis cartilage histopathology: grading and staging","volume":"14","author":"Pritzker","year":"2006","journal-title":"Osteoarthritis Cartilage."},{"issue":"9","key":"10.1016\/j.bone.2021.116264_bb0120","first-page":"1461","article-title":"What drives osteoarthritis?-synovial versus subchondral bone pathology","volume":"Sep 1\uff1b56","author":"T","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bone.2021.116264_bb0130","article-title":"Difference in the joint space of the medial knee compartment between full extension and Rosenberg weight-bearing radiographs","author":"Miura","year":"2021","journal-title":"Eur Radiol"},{"issue":"228","key":"10.1016\/j.bone.2021.116264_bb0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.lfs.2019.05.008","article-title":"Long noncoding RNA SNHG16 targets miR-146a-5p\/CCL5 to regulate LPS-induced WI-38 cell apoptosis and inflammation in acute pneumonia","volume":"1","author":"Zhou","year":"2019","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.bone.2021.116264_bb0140","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1097\/CORR.0000000000001520","article-title":"What general and pain-associated psychological distress phenotypes exist among patients with hip and knee Osteoarthritis?","volume":"478","author":"Lentz","year":"2020","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"1","key":"10.1016\/j.bone.2021.116264_bb0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0036933015619588","article-title":"Knee osteoarthritis: a review of management options","volume":"61","author":"Hussain","year":"2016","journal-title":"Scott Med. J."},{"key":"10.1016\/j.bone.2021.116264_bb0150","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biopha.2017.09.140","article-title":"A standardized extract of Butea monosperma (Lam.) flowers suppresses the IL-1\u03b2-induced expression of IL-6 and matrix-metalloproteases by activating autophagy in human osteoarthritis chondrocytes","volume":"96","author":"Ansari","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.bone.2021.116264_bb0155","first-page":"1723","article-title":"Targeting the A3 adenosine receptor for glaucoma treatment (review)","volume":"Jun;7","author":"P","year":"2013","journal-title":"Mol Med Rep"},{"issue":"7","key":"10.1016\/j.bone.2021.116264_bb0160","first-page":"1287","article-title":"Treatment of dry eye syndrome with orally administered CF101: data from a phase 2 clinical trial","volume":"Jul;117","author":"I","year":"2010","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.bone.2021.116264_bb0165","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ophtha.2010.11.026","article-title":"CF101 for dry eye","volume":"118","author":"Ashar","year":"2011","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.bone.2021.116264_bb0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1593\/neo.04364","article-title":"CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model","volume":"7","author":"Bar-Yehuda","year":"2005","journal-title":"Neoplasia."},{"issue":"8","key":"10.1016\/j.bone.2021.116264_bb0175","first-page":"931","article-title":"Treatment of plaque-type psoriasis with oral CF101: data from a phase II\/III multicenter, randomizedControlled Trial","volume":"15","author":"David","year":"2016","journal-title":"J. Drugs Dermatol."},{"issue":"10","key":"10.1016\/j.bone.2021.116264_bb0180","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.24817","article-title":"Induction of an anti-inflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment","volume":"60","author":"Bar-Yehuda","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"Suppl 120","key":"10.1016\/j.bone.2021.116264_bb0185","first-page":"57","article-title":"Innate inflammation and synovial macrophages in osteoarthritis pathophysiology","volume":"37","author":"Griffin","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bone.2021.116264_bb0190","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/561459","article-title":"The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis","volume":"2014","author":"Wojdasiewicz","year":"2014","journal-title":"Mediat. Inflamm."},{"issue":"10","key":"10.1016\/j.bone.2021.116264_bb0195","first-page":"13671","article-title":"Resistin enhances IL-1\u03b2 and TNF-\u03b1 expression in human osteoarthritis synovial fibroblasts by inhibiting miR-149 expression via the MEK and ERK pathways","volume":"Oct;34","author":"WC","year":"2020","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bone.2021.116264_bb0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrrheum.2010.196","article-title":"Role of proinflammatory cytokines in the pathophysiology of osteoarthritis","volume":"7","author":"Kapoor","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bone.2021.116264_bb0205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bcp.2019.02.036","article-title":"Chondrocyte dedifferentiation and osteoarthritis (OA)","volume":"165","author":"Charlier","year":"2019","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.bone.2021.116264_bb0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bcp.2019.02.033","article-title":"Inhibition of MMPs and ADAM\/ADAMTS","volume":"165","author":"Malemud","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"Suppl","key":"10.1016\/j.bone.2021.116264_bb0215","first-page":"2","article-title":"Type II collagen degradation and its regulation in articular cartilage in osteoarthritis","volume":"61","author":"Poole","year":"2002","journal-title":"Ann Rheum Dis."},{"issue":"4","key":"10.1016\/j.bone.2021.116264_bb0220","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bcp.2008.05.032","article-title":"The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB\/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats","volume":"76","author":"Ochaion","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bone.2021.116264_bb0225","first-page":"400","article-title":"IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis","volume":"24","author":"Rath-Wolfson","year":"2006","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.bone.2021.116264_bb0230","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrrheum.2011.109","article-title":"Autophagy and cartilage homeostasis mechanisms in joint health, aging and OA","volume":"7","author":"Lotz","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bone.2021.116264_bb0235","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/annrheumdis-2011-200557","article-title":"Autophagy activation by rapamycin reduces severity of experimental osteoarthritis","volume":"71","author":"Carames","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2021.116264_bb0245","article-title":"The Role of Autophagy in Chondrocyte Metabolism and Osteoarthritis: A Comprehensive Research Review","volume":"2019 Apr 14;2019:5171602.","author":"P","year":"2019","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.bone.2021.116264_bb0255","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0076-6879(08)03606-9","article-title":"Assays to assess autophagy induction and fusion of autophagic vacuoles with a degradative compartment, using monodansylcadaverine (MDC) and DQ-BSA","volume":"452","author":"V\u00e1zquez","year":"2009","journal-title":"Methods Enzymol."},{"issue":"11","key":"10.1016\/j.bone.2021.116264_bb0260","article-title":"Myrislignan induces redox imbalance and activates autophagy in Toxoplasma gondii","volume":"3","author":"Zhang","year":"2021","journal-title":"Front Cell Infect Microbiol."},{"key":"10.1016\/j.bone.2021.116264_bb0265","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biomaterials.2019.03.022","article-title":"miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis","volume":"206","author":"Wu","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.bone.2021.116264_bb0270","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.biopha.2017.01.130","article-title":"Inhibition of PI3K\/AKT\/mTOR signaling pathway promotes autophagy of articular chondrocytes and attenuates inflammatory response in rats with osteoarthritis","volume":"89","author":"Xue","year":"2017","journal-title":"Biomed Pharmacother."},{"key":"10.1016\/j.bone.2021.116264_bb0275","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.arr.2016.04.003","article-title":"Age-related changes in AMPK activation: Role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways","volume":"28","author":"Salminen","year":"2016","journal-title":"Ageing Res. Rev."},{"issue":"12","key":"10.1016\/j.bone.2021.116264_bb0280","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1097\/CORR.0000000000001520","article-title":"What general and pain-associated psychological distress phenotypes exist among patients with hip and knee osteoarthritis?","volume":"478","author":"Lentz","year":"2020","journal-title":"Clin Orthop Relat Res."},{"issue":"114","key":"10.1016\/j.bone.2021.116264_bb0285","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuropharm.2016.11.026","article-title":"Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms","volume":"1","author":"Carlin","year":"2017","journal-title":"Neuropharmacology."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221004300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221004300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:43:50Z","timestamp":1762659830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221004300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":51,"alternative-id":["S8756328221004300"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116264","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CF101 alleviates OA progression and inhibits the inflammatory process via the AMP\/ATP\/AMPK\/mTOR axis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116264"}}